TLR4 and neoplasm: OM-174 is a triacyl lipid A analog that activates TLR4 and culminates in tumor growth regression by increasing the IFN-γ production (124, 125) This is well-tolerated at biological concentrations with strong antitumor effects (NCT01800812) (126).